throbber

`

`

`

`42
`
`OVERVIEW, BASIC PRINCIPLES AND METHODOLOGY
`
`anilines [71]. There are some deviations from the parabolic relationship
`when drugs are of varied chemical structure and molecular weight [51] 0
`This is mainly because various compounds have different transcellular
`pathways for penetration. Low molecular weight alcohols and ionized
`forms of drugs such as pilocarpine [72], cromolyn sodium [73] and sul(cid:173)
`fonamides [74] penetrate through less co'mmon paracellular pathways.
`Enzymatic lability also influences the extent of penetration of prodrugs
`into the cornea. The penetration of aliphatic timolol esters across the cornea
`of rabbits shows enzymatic lability [70,75]. The rate of diffusion in the
`cornea increases with increase in the rate ofhydrolysis of esters of prodrugs.
`Therefore, enzymatically susceptible straight chain alkyl esters penetrate
`more easily as compared to less susceptible branched chain alkyl esters of
`same lipophilicity. That is the reason why an esterase inhibitor decreases
`the corneal penetration of 0-butyryltimolol, 1 '-methylcyclopro(cid:173)
`panolytimolol and 0-pivaloyltimolol by 30, 50 and 80% respectively [75] 0
`When prodrug of pilocarpine is administered to the tear film, it is envisioned
`that the controlling factor for corneal penetration is the formation of
`pilocarpine in the epithelium instead of its absorption into the epithelium or
`its diffusion across the stroma to the endothelium.
`
`MICELLAR SOLUBILIZATION
`
`Solubilization in surfactant solutions above the critical micelle concentra(cid:173)
`tion (CMC) offers a very good method to formulate dosage forms of poorly
`soluble drugs in water. Because of their relatively nontoxic nature, nonionic
`surfactants have been used most frequently for drug solubilization. A new
`class of nonionic surface active polymers, polyoxy-ethylene-polyoxy(cid:173)
`propylene block copolymers, are also gaining a lot of attention due to their
`nontoxic nature. Different drugs behave differently when they are solubi(cid:173)
`lized in a surfactant system. Some drugs get inactivated, whereas others
`show higher activity.
`The properties such as solubility, diffusion coefficient, and lipid-water
`partitioning coefficient of drug-penetration enhancer complexes may differ
`significantly from the properties of individual components, i.e., the proper(cid:173)
`ties of the free drug or penetration enhancer. This is mainly due to the
`formation of mixed micelles. Mixed micelles of bile salt and insulin provide
`a high juxtamembrane concentration of soluble insulin which results in high
`flow rate of insulin monomers from the nares (nostrils) into the nasal
`membranes [76]. The effects of various lipid-bile salt mixed micelles on
`intestinal absorption of streptomycin were reported using in situ closed-loop
`method in rats [77]. While mixed micelles composed of monoolein or
`unsaturated fatty acids markedly enhanced the absorption of streptomycin,
`saturated fatty acids caused only a small enhancement of absorption, and
`
`Innopharma EX1021, Page 3
`
`

`

`

`

`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket